会員登録
ログイン
【4575】キャンバス
創薬ベンチャー。抗がん剤を開発。
類似企業：
【業界1位】
小野薬品工業
【業界1位】
小野薬品工業
売上高
営業利益
経常利益
当期利益
業績予想修正
対前回修正率
当初予想比較
| 決算期 | 日付 | 予・実 | 売上高 (百万円) | 対前回 | 営業利益 (百万円) | 対前回 | 経常利益 (百万円) | 対前回 | 当期利益 (百万円) | 対前回 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024.06 | 2024/08/09 | 実 | 0 | - | -1,262 | ↑ | -1,208 | ↑ | -1,209 | ↑ |
| 2024.06 | 2024/06/25 | 当初予 | - | - | -1,363 | - | -1,369 | - | -1,371 | - |
| 2023.06 | 2023/08/10 | 実 | 0 | - | -965 | ↓ | -1,283 | ↑ | -1,244 | ↑ |
| 2023.06 | 2023/07/03 | 当初予 | - | - | -958 | - | -1,284 | - | -1,245 | - |
| 2022.06 | 2022/08/12 | 実 | 0 | - | -846 | ↑ | -854 | ↑ | -855 | ↑ |
| 2022.06 | 2022/07/01 | 当初予 | - | - | -860 | - | -871 | - | -872 | - |
| 2021.06 | 2021/08/13 | 実 | 108 | - | -547 | - | -555 | - | -531 | - |
| 2020.06 | 2020/08/11 | 実 | 110 | → | -566 | ↑ | -573 | ↑ | -572 | ↑ |
| 2020.06 | 2020/05/13 | Q3予 | 110 | → | -709 | → | -712 | → | -713 | → |
| 2020.06 | 2020/02/12 | Q2予 | 110 | → | -709 | → | -712 | → | -713 | → |
| 2020.06 | 2020/01/27 | 修正予 | 110 | → | -709 | ↑ | -712 | ↑ | -713 | ↑ |
| 2020.06 | 2019/12/03 | 修正予 | 110 | → | -720 | → | -723 | → | -724 | → |
| 2020.06 | 2019/12/02 | 修正予 | 110 | → | -720 | ↓ | -723 | ↓ | -724 | ↓ |
| 2020.06 | 2019/11/12 | Q1予 | 110 | → | -667 | → | -667 | → | -669 | → |
| 2020.06 | 2019/08/13 | 当初予 | 110 | - | -667 | - | -667 | - | -669 | - |
| 2019.06 | 2019/08/13 | 実 | 115 | → | -533 | ↑ | -534 | ↑ | -456 | ↑ |
| 2019.06 | 2019/05/14 | Q3予 | 115 | → | -611 | → | -609 | → | -530 | → |
| 2019.06 | 2019/02/12 | Q2予 | 115 | → | -611 | → | -609 | → | -530 | → |
| 2019.06 | 2018/12/18 | 修正予 | 115 | → | -611 | ↑ | -609 | ↑ | -530 | ↑ |
| 2019.06 | 2018/11/13 | Q1予 | 115 | → | -851 | → | -851 | → | -852 | → |
| 2019.06 | 2018/08/14 | 当初予 | 115 | - | -851 | - | -851 | - | -852 | - |
| 2018.06 | 2018/08/14 | 実 | 110 | → | -539 | ↑ | -547 | ↑ | -532 | ↑ |
| 2018.06 | 2018/05/14 | Q3予 | 110 | → | -600 | → | -600 | → | -601 | → |
| 2018.06 | 2018/02/13 | Q2予 | 110 | → | -600 | → | -600 | → | -601 | → |
| 2018.06 | 2017/11/13 | Q1予 | 110 | → | -600 | → | -600 | → | -601 | → |
| 2018.06 | 2017/08/10 | 当初予 | 110 | - | -600 | - | -600 | - | -601 | - |
| 2017.06 | 2017/08/10 | 実 | 109 | ↓ | -406 | ↑ | -400 | ↑ | -419 | ↑ |
| 2017.06 | 2017/05/12 | Q3予 | 110 | → | -465 | → | -466 | → | -467 | → |
| 2017.06 | 2017/02/13 | Q2予 | 110 | → | -465 | → | -466 | → | -467 | → |
| 2017.06 | 2017/01/04 | 修正予 | 110 | ↑ | -465 | ↑ | -466 | ↑ | -467 | ↑ |
| 2017.06 | 2016/11/11 | Q1予 | 105 | → | -630 | → | -630 | → | -631 | → |
| 2017.06 | 2016/08/12 | 当初予 | 105 | - | -630 | - | -630 | - | -631 | - |
| 2016.06 | 2016/08/12 | 実 | 105 | → | -399 | ↓ | -413 | ↓ | -414 | ↓ |
| 2016.06 | 2016/05/13 | Q3予 | 105 | → | -343 | → | -343 | → | -344 | → |
| 2016.06 | 2016/02/12 | Q2予 | 105 | → | -343 | → | -343 | → | -344 | → |
| 2016.06 | 2015/11/13 | Q1予 | 105 | → | -343 | - | -343 | → | -344 | → |
| 2016.06 | 2015/08/13 | 当初予 | 105 | - | - | - | -343 | - | -344 | - |
| 2015.06 | 2015/08/13 | 実 | - | - | - | - | - | - | - | - |
| 2015.06 | 2015/06/16 | 修正予 | 60 | ↓ | - | - | -265 | ↓ | -266 | ↓ |
| 2015.06 | 2015/05/14 | Q3予 | 560 | → | 245 | → | 258 | → | 258 | → |
| 2015.06 | 2015/02/13 | Q2予 | 560 | → | 245 | → | 258 | → | 258 | → |
| 2015.06 | 2014/12/26 | 修正予 | 560 | ↑ | 245 | ↑ | 258 | ↑ | 258 | ↑ |
| 2015.06 | 2014/11/14 | Q1予 | 525 | → | 191 | → | 191 | → | 190 | → |
| 2015.06 | 2014/08/12 | 当初予 | 525 | - | 191 | - | 191 | - | 190 | - |
| 2014.06 | 2014/08/12 | 実 | 0 | → | -483 | ↑ | -480 | ↓ | -376 | ↓ |
| 2014.06 | 2014/06/20 | 修正予 | 0 | ↓ | -484 | ↓ | -479 | ↓ | -375 | ↓ |
| 2014.06 | 2014/03/17 | 当初予 | 500 | - | 11 | - | 11 | - | 113 | - |
